Tribunal held that the Commissioner (Appeals) erred in deciding classification without first addressing limitation under Section 129D(3) of the Customs Act, and remanded the case for fresh ...
NICE has rejected the use of AstraZeneca and Daiichi Sankyo’s Enhertu as an NHS treatment for advanced HER2-low breast cancer, a decision that the companies have described as “devastating”. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback